In the recent "IDC FutureScape: Worldwide Health Industry 2021 Predictions" report, experts at IDC Health Insights offer their thoughts about the issues healthcare and life science organizations will contend with over the next year and beyond.

Under the proposed rule, providers would be able to disclose patient data if they believe it's in the patient's best interest.

Increases in spending on hospital care, physician services and prescription drugs squeezed U.S. commercial health insurers in 2019, according to new federal government health spending data.

Fed-up Californians have been trading their cramped, pricey apartments for affordable living in cheaper states for decades. Now, California’s businesses are making similar calculations after a months long remote work experiment triggered by the pandemic.

Pfizer said Wednesday it will supply the U.S. government with an additional 100 million doses of its COVID-19 vaccine under a new agreement between the pharmaceutical giant and the Trump administration. Pfizer and its German partner BioNTech said that will bring their total current commitment to 200 million doses for the U.S. That should be ...

The Senate voted in the wee hours of Tuesday morning to repeal insurers’ federal antitrust enforcement immunity, sending the bill to the president’s desk. The Competitive Health Insurance Reform Act would amend the 1945 McCarran-Ferguson Act, which gave insurers federal immunity from antitrust enforcement and delegated primary authority to regulate consolidation in the insurance industry. ...